Fundacion Hospital de Alcorcon; Servicio de Digestivo

Alcorcón, Madrid 28922

0 studies enrolling now · 2 studies all time

What they study most

Ulcerative Colitis

Studies at this site

• Study for Participants With Ulcerative Colitis Previously Enrolled in Etrolizumab Phase II/III Studies — Stopped early
• A Study of the Efficacy and Safety of Etrolizumab in Participants With Ulcerative Colitis Who Have Been Previously Exposed to Tumor Necrosis Factor (TNF) Inhibitors — Completed